Business Context and Reporting Period
This Form 8-K is a current report filed by Global Medical REIT Inc. (not Chiron Real Estate Inc.) on March 7, 2019, covering events occurring on March 5 and March 6, 2019. The filing primarily addresses the announcement of Q4 and full-year 2018 financial results, the approval of 2019 executive compensation plans, and the declaration of dividends.
Key Financial Metrics and Dividends
The filing references the release of Q4 and full-year 2018 earnings results but does not contain specific revenue, profit, or cash flow figures within the text of this report; those details are contained in the attached Exhibit 99.1.
- Common Stock Dividend: $0.20 per share for Q1 2019. Record date: March 26, 2019; Payment date: April 10, 2019.
- Series A Preferred Stock Dividend: $0.46875 per share. Record date: April 15, 2019; Payment date: April 30, 2019.
- Liquidity/Debt: Specific debt balances and liquidity positions are not disclosed in this text, though leverage ratios are used as performance metrics for executive compensation.
Material Changes and Executive Compensation
On March 5, 2019, the Board approved significant 2019 equity incentive awards under the 2016 Equity Incentive Plan. These awards are performance-based and time-based.
2019 Annual Performance-Based Awards (LTIP)
Awards are based on four components (25% weight each): Acquisitions, AFFO per share, Consolidated Leverage Ratio, and a Discretionary Component.
| Executive | Title | Target Value | Target Units |
|---|---|---|---|
| Jeffrey Busch | CEO, Chairman & President | $180,000 | 17,875 |
| Alfonzo Leon | CIO | $150,000 | 14,896 |
| Robert Kiernan | CFO & Treasurer | $150,000 | 14,896 |
| Jamie Barber | General Counsel & Secretary | $120,000 | 11,917 |
| Allen Webb | SVP, SEC Reporting | $110,000 | 10,924 |
Performance Goals for 2019:
- Acquisitions: Target $150 million (Threshold $100M; Max $200M).
- AFFO per Share: Target $0.80 (Threshold $0.78; Max $0.84).
- Leverage Ratio: Target 52.50% (Threshold 54.99%; Max 49.99%).
2019 Long-Term Awards
Long-term awards vest over three years and are based on Total Shareholder Return (TSR) relative to peers and absolute performance.
| Executive | Performance Award Target | Time-Based Award Target |
|---|---|---|
| Jeffrey Busch | $138,000 (13,849 units) | $92,000 (9,136 units) |
| Alfonzo Leon | $126,000 (12,645 units) | $84,000 (8,342 units) |
| Robert Kiernan | $96,000 (9,634 units) | $64,000 (6,356 units) |
| Jamie Barber | $84,000 (8,430 units) | $56,000 (5,561 units) |
| Allen Webb | $78,000 (7,828 units) | $52,000 (5,164 units) |
Director Compensation
Independent directors receive a $40,000 annual cash retainer and a $40,000 annual equity award. Additional retainers apply for committee service and chairmanship.
Guidance, Outlook, and Risks
The filing does not provide explicit forward-looking guidance on revenue or earnings beyond the performance targets set for executive compensation. The compensation structure implies management's focus on maintaining a leverage ratio below 55%, achieving $150M in acquisitions, and growing AFFO to $0.80 per share in 2019.
Risks and Contingencies: Executive awards are subject to forfeiture if performance thresholds are not met. Vesting accelerates upon Change of Control, death, disability, or retirement, but unvested awards are forfeited upon other terminations.
Investor Verification Checklist
- Review Exhibit 99.1 for the actual Q4 and full-year 2018 financial results (Revenue, Net Income, FFO, Debt levels) as they are not detailed in this 8-K text.
- Verify the Series A Preferred Stock dividend payment schedule and record dates.
- Monitor the company's progress toward the 2019 Acquisition Target of $150 million to assess executive compensation payout potential.
- Track the Consolidated Leverage Ratio quarterly to ensure it remains below the 54.99% threshold required for any executive award payout.
- Confirm the AFFO per share guidance for 2019 aligns with the $0.80 target set in the compensation plan.